Next-generation DNA sequencing identifies mutated FANCD2 Gene as a novel Biomarker for monitoring early disease progression and timely therapeutic interventions in advanced phase Chronic Myeloid Leukemia patients

Nawaf Alanazi, Abdulaziz Siyal, Muhammad Absar, Masood Shammas, Sarah Al-Mukhaylid, Amer Mahmood, Zafar Iqbal
doi: https://doi.org/10.1101/2023.12.19.23300103

Article usage

Article usage: December 2023 to August 2025

AbstractFullPdf
Dec 2023131617
Jan 202499514
Feb 2024751116
Mar 202433917
Apr 202431913
May 20242938
Jun 202431914
Jul 202419310
Aug 202418311
Sep 202423910
Oct 202426521
Nov 20241843
Dec 202412217
Jan 202533213
Feb 2025357212
Mar 2025268728
Apr 2025312025
May 2025391934
Jun 2025342319
Jul 2025261717
Aug 2025407
Back to top
Posted January 29, 2024.
Download PDF
Data/Code
Email
Next-generation DNA sequencing identifies mutated FANCD2 Gene as a novel Biomarker for monitoring early disease progression and timely therapeutic interventions in advanced phase Chronic Myeloid Leukemia patients
Nawaf Alanazi, Abdulaziz Siyal, Muhammad Absar, Masood Shammas, Sarah Al-Mukhaylid, Amer Mahmood, Zafar Iqbal
medRxiv 2023.12.19.23300103; doi: https://doi.org/10.1101/2023.12.19.23300103
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area